25.12.2012 Views

Risikomanagement in der Rückversicherung - Ihr ...

Risikomanagement in der Rückversicherung - Ihr ...

Risikomanagement in der Rückversicherung - Ihr ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Europäisches Forum Alpbach 2008<br />

<strong>Risikomanagement</strong> <strong>in</strong> <strong>der</strong><br />

<strong>Rückversicherung</strong><br />

Dr. Ra<strong>in</strong>er Sachs<br />

Münchener Rück<br />

27. August 2008


Leitfragen zum Thema<br />

• Was verstehen wir unter Enterprise Risk Management, woher & woh<strong>in</strong>?<br />

• Wie sieht die <strong>Risikomanagement</strong> Struktur und die Aufgaben <strong>in</strong> <strong>der</strong><br />

<strong>Rückversicherung</strong> aus?<br />

• „E<strong>in</strong> Modell ist e<strong>in</strong> Modell ist e<strong>in</strong> Modell ist e<strong>in</strong> Modell!“<br />

• Warum s<strong>in</strong>d Emerg<strong>in</strong>g Risks wichtig für die (Rück-)Versicherung und<br />

wie gehen wir damit um?<br />

• Wie kam es zur „Subprime-Krise“ und was ist das überhaupt?<br />

• Wie sieht die Zukunft des <strong>Risikomanagement</strong>s aus?<br />

2


Enterprise Risk Management<br />

Die Anfor<strong>der</strong>ungen an das <strong>Risikomanagement</strong><br />

nehmen zu – <strong>in</strong>tern wie extern<br />

Rat<strong>in</strong>g Agenturen Aufsichtsbehörden<br />

Source: S&P New Insurance Enterprise Risk Management Evaluation Criteria,<br />

October 19, 2005<br />

Quantitative<br />

Requirements<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Solvency II<br />

Supervisory<br />

review<br />

process<br />

Disclosure<br />

Transparency<br />

Measures to<br />

foster market<br />

discipl<strong>in</strong>e<br />

Entwicklung e<strong>in</strong>es ganzheitlichen Ansatzes → Enterprise Risk Management<br />

27. August 2008<br />

3


Enterprise Risk Management<br />

Die Entwicklung <strong>der</strong> Rolle von<br />

Enterprise Risk Management<br />

Fokus <strong>der</strong> VU<br />

Phasen <strong>der</strong><br />

Entwicklung<br />

von ERM<br />

2. Hälfte 90-er Jahre<br />

«Boom»<br />

� Wachstum<br />

� <strong>Risikomanagement</strong> durch<br />

diverse E<strong>in</strong>heiten im<br />

Versicherungs-<br />

Unternehmen<br />

� Ke<strong>in</strong>e o<strong>der</strong> wenig<br />

Koord<strong>in</strong>ation<br />

� Ansätze von Risikomodellierung<br />

und Asset-<br />

Liability-Mgmt<br />

2003 – 2006<br />

Krise «Konsolidierung» Vertrauen<br />

Wie<strong>der</strong>herstellung von:<br />

� EK-Grundlage<br />

� Ertragskraft<br />

� Glaubwürdigkeit<br />

E<strong>in</strong>richtung von:<br />

� zentralen RM-<br />

Teams unter CRO<br />

� RM Regeln und<br />

Berichtswesen<br />

� Risikomodellen<br />

� Anwendung von marktkonsistenten<br />

EEVs<br />

� verbessertes ALM<br />

2007…<br />

«Profitables Wachstum»<br />

� Ausrichtung auf profitables<br />

Wachstum<br />

� Aktives Management von<br />

Überschuss-kapital<br />

� Strategisches Risiko-<br />

Management<br />

� Impuls zur Entwicklung<br />

neuer Produkte (z.B.<br />

Variable Annuities)<br />

� Nutzen von Solvency II als<br />

e<strong>in</strong>e Opportunität <strong>in</strong> <strong>der</strong><br />

<strong>Rückversicherung</strong><br />

Rolle von ERM Entwicklungsansätze Emanzipation Bus<strong>in</strong>ess “Bus<strong>in</strong>ess Enabler Enabler”<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

4


Enterprise Risk Management<br />

ERM erfor<strong>der</strong>t e<strong>in</strong>e strikte Trennung von<br />

Verantwortlichkeiten und Kontrollen<br />

Bus<strong>in</strong>ess Management / Risk Owners Independent Risk Management<br />

• Bus<strong>in</strong>ess Plann<strong>in</strong>g<br />

• Identify and evaluate risks<br />

• Take steps to manage / mitigate all risks<br />

associated with their bus<strong>in</strong>ess<br />

• Manage and own risks of all approved<br />

transactions regardless of ultimate approval<br />

level<br />

Internal Audit<br />

Board of Management<br />

• Approves bus<strong>in</strong>ess strategy<br />

• Sets risk appetite and expected risk-adjusted returns<br />

• Resource and capital allocation<br />

• Clear mandate by the Board to ensure that<br />

for all classes of risk appropriate limits,<br />

policies, procedures and measures are <strong>in</strong><br />

place with<strong>in</strong> each Bus<strong>in</strong>ess Unit<br />

• Aggregate and monitor group-wide risks<br />

(e.g. risk capital) and report to Board<br />

• Develop risk mitigation strategies<br />

• Act as a risk consultant to Bus<strong>in</strong>ess Units<br />

Audit function <strong>in</strong>dependently verifies that effective controls are <strong>in</strong> place and function<strong>in</strong>g properly<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

5


Aufbau des <strong>Risikomanagement</strong>s<br />

Integriertes Risiko Management <strong>in</strong> <strong>der</strong> MR –<br />

Struktur folgt dem RM Prozess<br />

Risk Identification<br />

& Control<br />

� Risk assessment /<br />

risk report<strong>in</strong>g<br />

� Risk disclosure<br />

� Emerg<strong>in</strong>g risks<br />

management<br />

� Operational risk<br />

management<br />

� Accumulation control<br />

Risk Analytics &<br />

Report<strong>in</strong>g<br />

� Development and ma<strong>in</strong>te-<br />

nance of risk models<br />

� Legal entity models<br />

� Risk capital calculations<br />

� Allocation of risk capital for<br />

VBM purposes<br />

� Scenario calibration<br />

� Structure aligned with risk management process<br />

Risk Strategy /<br />

Asset & Liability<br />

Management<br />

� Strategic Risk<br />

Management Framework<br />

� Strategic ALM<br />

� Limits and Triggers<br />

System<br />

� Risk Management<br />

Governance<br />

� Risk reviews and new<br />

product approval<br />

� Bus<strong>in</strong>ess liaison roles designed to “embed” risk management tools and processes <strong>in</strong> our daily bus<strong>in</strong>ess<br />

� IRM reports to the Group CRO, i.e. is <strong>in</strong>dependent from the risk tak<strong>in</strong>g process<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Solvency<br />

Consult<strong>in</strong>g<br />

� Identify and support new<br />

bus<strong>in</strong>ess opportunities<br />

� Enable operational units<br />

to display the additional<br />

value of re<strong>in</strong>surance<br />

� Strengthen client<br />

relationship through<br />

Solvency II-related advice<br />

and service<br />

27. August 2008<br />

6


Enterprise Risk Management<br />

Sichtbares Ergebnis des <strong>Risikomanagement</strong>s:<br />

Signifikante Reduktion <strong>der</strong> Kapitalkosten<br />

Investment risks<br />

� Lowered equity gear<strong>in</strong>g<br />

� Reduced concentration risks<br />

� Low credit risk<br />

Asset-liability management<br />

� State-of-the-art ALM<br />

� Strong risk management<br />

Insurance risks<br />

� Active cycle management<br />

� High diversification<br />

� Strong Group reserves<br />

Beta factor Munich Re and <strong>in</strong>dustry<br />

Source: Bloomberg raw beta to DJ Stoxx 600, total return, daily basis, 1-year. Status 30 April 2008.<br />

2.2<br />

2.0<br />

1.8<br />

1.6<br />

1.4<br />

1.2<br />

1.0<br />

0.8<br />

0.6<br />

Significantly<br />

reduced to<br />

below 0.8 for<br />

Munich Re<br />

2004 2005 2006 2007 2008<br />

Munich Re DJ EuroStoxx Insurance<br />

De-risk<strong>in</strong>g reflected <strong>in</strong> significant<br />

reduction of cost of capital<br />

Munich Re<br />

now well<br />

below <strong>in</strong>dustry<br />

7


Risiko-Identifikation –<br />

Emerg<strong>in</strong>g Risk Management<br />

8


Was s<strong>in</strong>d Emerg<strong>in</strong>g Risks?<br />

Def<strong>in</strong>ition und Eigenschaften von<br />

Emerg<strong>in</strong>g Risks<br />

Emerg<strong>in</strong>g risks comprise new and develop<strong>in</strong>g risks and their related<br />

bus<strong>in</strong>ess opportunities for the <strong>in</strong>surance <strong>in</strong>dustry.<br />

They result from changes <strong>in</strong> risk factors with a high degree of uncerta<strong>in</strong>ty<br />

<strong>in</strong> terms of occurrence probability and loss amounts, and with a<br />

substantial potential impact on the company’s risk profile.<br />

Key characteristics:<br />

� Driven by environmental, technological, social, economic or legal changes<br />

� L<strong>in</strong>k between cause and effect not proven<br />

� Catastrophe potential across <strong>in</strong>surance l<strong>in</strong>es and balance sheet<br />

� Difficult to quantify (frequency / severity)<br />

� Often long-term exposure<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

9


Was s<strong>in</strong>d Emerg<strong>in</strong>g Risks?<br />

“Vorhersagen s<strong>in</strong>d sehr schwierig –<br />

<strong>in</strong>sbeson<strong>der</strong>e wenn sie die Zukunft betreffen!”<br />

Normale Risiken<br />

Kfz<br />

Erdbeben<br />

Stürme<br />

...<br />

Emerg<strong>in</strong>g Risks<br />

Genetic<br />

Eng<strong>in</strong>eer<strong>in</strong>g<br />

Nanotechnology<br />

...<br />

Verlust<br />

Vergangenheit Zukunft<br />

0 ?<br />

Vergangenheit Zukunft<br />

10


Was s<strong>in</strong>d Emerg<strong>in</strong>g Risks?<br />

Emerg<strong>in</strong>g Risks können als abruptes Ereignis o<strong>der</strong><br />

als schleichende Verän<strong>der</strong>ung auftreten<br />

Mortality rates from<br />

<strong>in</strong>fectious diseases<br />

per 100,000 US<br />

population<br />

900<br />

800<br />

700<br />

600<br />

500<br />

400<br />

300<br />

200<br />

100<br />

Spanish flu,<br />

1918/19<br />

65<br />

60<br />

55<br />

50<br />

45<br />

40<br />

AIDS<br />

35<br />

1980 1982 1984 1986 1988 1990 1992 1994<br />

30<br />

25<br />

0<br />

1900 1910 1920 1930 1940 1950 1960 1970 1980 1990<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Source: Prevent<strong>in</strong>g Emerg<strong>in</strong>g Infectious Diseases –<br />

A Strategy for the 21st Century, CDC<br />

27. August 2008<br />

11


Warum befassen wir uns mit Emerg<strong>in</strong>g Risks?<br />

Die Zeiten än<strong>der</strong>n sich<br />

Globalisation<br />

US products<br />

liability<br />

Increas<strong>in</strong>g claims<br />

awareness<br />

Worldwide travel<br />

Communication<br />

Media – always and<br />

everywhere accessible<br />

Quick spread of<br />

<strong>in</strong>formation via the<br />

Internet<br />

Shared risk perception<br />

New technologies<br />

Bio-, Nanotechnology<br />

IT, Wireless LAN, new materials<br />

Regulatory environment<br />

Complexity<br />

Stricter legal and regulatory<br />

requirements (dto. rat<strong>in</strong>g agencies)<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Shorter <strong>in</strong>novation cycles<br />

Increas<strong>in</strong>g <strong>in</strong>terconnectedness<br />

of risk<br />

Increas<strong>in</strong>g value<br />

concentration<br />

Sharehol<strong>der</strong> Value<br />

Image, reputation<br />

Protection of sharehol<strong>der</strong><br />

capital<br />

27. August 2008<br />

12


Warum befassen wir uns mit Emerg<strong>in</strong>g Risks?<br />

“Core Global Risks” des World Economic Forum –<br />

alle können die Versicherungs<strong>in</strong>dustrie treffen<br />

Source: World Economic Forum, “Global Risk Report 2008”, January 2008<br />

27. August 2008<br />

13


Beispiel<br />

Intra-l<strong>in</strong>e Akkumulation: Asbest –<br />

Von Berufserkrankungen zu Produkthaftpflicht<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

14


Beispiel<br />

Globale Pandemie – e<strong>in</strong>e komplexe Risikosituation<br />

mit vielen Facetten<br />

+ BCM<br />

Biometrical data<br />

� Age groups potentially affected<br />

� Hospitalization, <strong>in</strong>tensive care units<br />

� Costs of treatment<br />

� Length of absenteeism<br />

� Death toll<br />

Example: Swiss<br />

Solvency Test<br />

(SST)<br />

Exposure<br />

Stress test<br />

of portfolio<br />

analysis<br />

Flu<br />

Pandemic pandemic<br />

Scenario<br />

establishment<br />

Science/<br />

Medic<strong>in</strong>e:<br />

Monitor<strong>in</strong>g<br />

SARS:<br />

Learn<strong>in</strong>g<br />

from the<br />

past<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Medical risk factors<br />

� Virus transmission and spread, virulence<br />

� Waves of pandemic (length, frequency)<br />

� Preparedness of health care systems<br />

� Availability and efficacy of drugs and<br />

vacc<strong>in</strong>es<br />

27. August 2008<br />

16


Beispiel<br />

Shell – Bereit für den Krisenfall<br />

Beg<strong>in</strong>n<strong>in</strong>g of 1970’s<br />

� Shell plann<strong>in</strong>g group focus<strong>in</strong>g on<br />

factors/events <strong>in</strong>fluenc<strong>in</strong>g the oil price<br />

� Strategy development tak<strong>in</strong>g <strong>in</strong>to account<br />

potential wild card …<br />

� Core strategy based on assumption of<br />

cont<strong>in</strong>uation of past oil price movements<br />

� Alternative strategy based on “wild card”<br />

significant oil price <strong>in</strong>crease due to<br />

supply limitation<br />

� Be<strong>in</strong>g prepared for wild card – def<strong>in</strong>ition of …<br />

� Required precautionary measures<br />

� Respective strategic options and<br />

operative actions<br />

Source: Munich Re, Corporate Development; Shell<br />

1973 oil crisis<br />

� Oil price quadrupled due to limited<br />

supply follow<strong>in</strong>g Yom Kippur war<br />

� Shell able to significantly strengthen<br />

market position with<strong>in</strong> crisis due to fast<br />

implementation of measures predef<strong>in</strong>ed<br />

<strong>in</strong> scenarios<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

17


Ergebnis<br />

Emerg<strong>in</strong>g Risks erfor<strong>der</strong>n neue, ganzheitliche<br />

Ansätze im Risiko Management<br />

Source: Wharton Risk Centre with Data<br />

from Insurance Information Institute<br />

Source: Climate Change Impacts Europe: Today and <strong>in</strong> the<br />

future, European environmental Agency, Copenhagen 2004<br />

Cross-balance sheet impact of pharma loss<br />

Man-made disasters – Higher value concentration Global spread – Higher complexity<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Source: Hufnagel, L. et al. (2004) Proc. Natl. Acad.<br />

Sci. USA Vol. 101, No. 42, pp. 15124-15129; Copy-<br />

right ©2004 by the National Academy of Sciences<br />

27. August 2008<br />

18


Risiko-Analyse & Report<strong>in</strong>g –<br />

MR Capital Model<br />

19


Grundlagen <strong>der</strong> Bewertung<br />

Risikomessung unter ökonomischen<br />

Randbed<strong>in</strong>gungen<br />

In e<strong>in</strong>er ökonomischen Sicht gelten folgende<br />

Bewertungspr<strong>in</strong>zipien:<br />

� Kapitalanlagen werden marktkonsistent<br />

bewertet. Dies bedeutet e<strong>in</strong>e mark-to-market<br />

Bewertung, wo Marktpreise vorhanden s<strong>in</strong>d<br />

o<strong>der</strong> e<strong>in</strong>e Mark-to-model Bewertung.<br />

� Verpflichtungen werden konsistent zu<br />

Bewertungspr<strong>in</strong>zipien aus dem Kapitalmarkt<br />

bewertet. Dies bedeutet z.B., dass Optionen<br />

und Garantien <strong>in</strong> <strong>der</strong> Lebenserstversicherung<br />

mit risiko-neutralen Bewertungstechniken<br />

bewertet werden.<br />

Ökonomische Bilanz<br />

Wert<br />

<strong>der</strong> Kapital-<br />

anlagen<br />

Eigenkapital<br />

Wert <strong>der</strong><br />

Verb<strong>in</strong>dlich-<br />

keiten<br />

Risikomessung nach unterschiedlichen Rechnungslegungsstandards möglich.<br />

Für die <strong>in</strong>terne Steuerung gilt die ökonomische Sichtweise.<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

20


Modellstruktur<br />

Risikokapital wird über e<strong>in</strong> Baukastensystem<br />

bestimmt<br />

Credit risk<br />

� Corporate<br />

bonds<br />

� Retrocession<br />

ceded<br />

� Other<br />

receivables<br />

Asset risk<br />

Market risk<br />

� Equities,<br />

property<br />

� Interest rate<br />

risk<br />

� Foreign<br />

exchange<br />

RISK<br />

Insurance risk<br />

P&C<br />

� NatCat and<br />

other large<br />

losses<br />

� Loss due to<br />

premium<br />

<strong>in</strong>sufficiency<br />

� Reserve<br />

uncerta<strong>in</strong>ty<br />

L&H<br />

� Mortality/<br />

longevity<br />

� Morbidity<br />

� Persistency<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Operational risk<br />

Bus<strong>in</strong>ess risk<br />

� Changes <strong>in</strong><br />

volume<br />

� Changes <strong>in</strong><br />

pric<strong>in</strong>g<br />

marg<strong>in</strong>s and<br />

expenses<br />

Event risk<br />

� Fraud<br />

� Errors<br />

� Systems<br />

<strong>in</strong>terruption<br />

27. August 2008<br />

21


Aggregation<br />

Zusammenführung <strong>der</strong> e<strong>in</strong>zelnen Risikosegmente<br />

Asset Risk<br />

Market Risk<br />

Credit Risk<br />

Risk<br />

Non-Life<br />

Risk<br />

Non-Life<br />

Basic Risk<br />

Non-Life<br />

Event Risk<br />

Life Risk<br />

The <strong>in</strong>dividual risks are<br />

aggregated <strong>in</strong>corporat<strong>in</strong>g<br />

their nonl<strong>in</strong>ear dependency<br />

structure (copula)<br />

represented by a rank<br />

correlation matrix and<br />

coefficients of upper tail<br />

dependency.<br />

22


Aggregation<br />

Modellierung von Tail Abhängigkeiten zwischen<br />

Risikofaktoren<br />

Risk factor 2<br />

no tail dependency<br />

Risk factor 1<br />

Risk factor 2<br />

tail dependency<br />

Risk factor 1<br />

In Munich Re’s risk model Copulas are used to <strong>in</strong>corporate tail<br />

dependencies, <strong>in</strong> particular between Non-Life Cat Risk and Asset Risk.<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

23


Risikomodellierung <strong>in</strong> <strong>der</strong> Münchener Rück –<br />

Standard Prozess mit Report<strong>in</strong>g zu den relevanten Parteien<br />

Risk capital report<strong>in</strong>g<br />

� Quarterly assessment of Economic Risk Capital (ERC) at ERGO and MR<br />

� Relevant bodies (e.g. Group risk committee, ERGO risk committee) discuss quarterly<br />

capital reports<br />

� ERC strongly embedded <strong>in</strong> key management processes, e.g.<br />

� Strategic Risk Management Framework (ALM, Insurance Risk steer<strong>in</strong>g, risk<br />

mitigation)<br />

� Capital allocation and pric<strong>in</strong>g<br />

� Performance measurement<br />

� Embedded <strong>in</strong> annual plann<strong>in</strong>g process<br />

� Consistent with pr<strong>in</strong>ciples of Solvency II<br />

� Annual disclosure (s<strong>in</strong>ce year end 2001)<br />

Risk model<strong>in</strong>g is a rout<strong>in</strong>e process that is embedded<br />

<strong>in</strong> relevant management applications<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

24


Risiko-Strategie –<br />

Strategic Risk Management Framework<br />

25


Solvency II und MaRisk<br />

Solvency II<br />

Anfor<strong>der</strong>ungen aus MaRisk<br />

MaRisk fokussieren den strategischen Rahmen des Unternehmens<br />

Vorstand / Leitung des VU<br />

verantwortlich für<br />

Geschäftsstrategie Risikostrategie<br />

<strong>Risikomanagement</strong><br />

<strong>Risikomanagement</strong> - Kreislauf Report<strong>in</strong>g<br />

Operatives Geschäft<br />

Geschäftsstrategie<br />

Nicht Gegenstand <strong>der</strong> Aufsicht!<br />

Risikostrategie (Auszug)<br />

� Formulierung von strategischen Zielen<br />

� Umgang mit vorhandenen Risiken<br />

� Risikotragfähigkeit für wesentliche<br />

potenzielle Risiken (Risikokapitalallokation)<br />

� Risikosteuerung (Limite)<br />

� Kontrollen<br />

� Berichtswesen<br />

Herausfor<strong>der</strong>ung:<br />

Bestimmung des Risikoappetits<br />

26


Strategic Risk Management Framework<br />

Risikoappetit<br />

Über wessen Risikoappetit sprechen wir?<br />

Kunden<br />

� Erwarten Produktleistung<br />

� Betroffen vom Risiko <strong>der</strong><br />

Insolvenz<br />

� Primär Downside Risiko, wenig<br />

Upside<br />

� Erwarten hohe<br />

Kapitalanfor<strong>der</strong>ung<br />

Management<br />

� Vertreter <strong>der</strong> Eigentümer<br />

� … aber auch von Kunden<br />

und Mitarbeitern<br />

� Möglichkeit von<br />

Interessenskonflikten<br />

(Pr<strong>in</strong>zipal-Agent Konflikt,<br />

„Moral Hazard“)<br />

Eigentümer / Aktionäre<br />

� Erwarten hohe Kapitalrendite<br />

(Dividenden,<br />

Aktienkursperfomance)<br />

� Chance auf Upside<br />

� Downside Risiko begrenzt<br />

(Limited Liability Put Option)<br />

Die Auswahl <strong>der</strong> im SRMF festgelegten Risikokriterien und Kalibrierung <strong>der</strong><br />

Limite berücksichtigt die Interessen unserer Kunden und unserer Aktionäre<br />

gleichermaßen<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

27


Strategic Risk Management Framework<br />

Strategic Risk Management Framework<br />

Ziele<br />

Sicht <strong>der</strong> Aufsicht<br />

Risikostrategie<br />

� Prüfung <strong>der</strong> Risikostrategie<br />

� Ziel: Konsistenz zwischen<br />

Risikoappetit und Geschäftstrategie!<br />

Letztendlich: Überprüfung <strong>der</strong><br />

Präzision <strong>der</strong> Unternehmens-<br />

steuerung!<br />

SRMF: Integriertes RM aus Sicht aller Stakehol<strong>der</strong><br />

Kunde/Rat<strong>in</strong>g Aktionär<br />

SRMF<br />

Aufsicht<br />

� SRMF ergänzt die Geschäftsstrategie aus Sicht<br />

aller Stakehol<strong>der</strong><br />

� Ziel: E<strong>in</strong> konsistentes, nachhaltiges<br />

Risikosteuerungssystem für alle Stakehol<strong>der</strong>!<br />

Synchronisation unterschiedlicher Präferenzen<br />

(VN, Aktionär, Aufsicht)!<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

28


Strategic Risk Management Framework<br />

Risikokriterien auf Gruppenebene<br />

Whole<br />

portfolio<br />

criteria<br />

Supplementary<br />

criteria<br />

Criterion Focus<br />

F<strong>in</strong>ancial strength Policyhol<strong>der</strong>s<br />

Avoid<strong>in</strong>g f<strong>in</strong>ancial<br />

distress<br />

Peak risk<br />

management<br />

Asset-liability<br />

mismatch<br />

Sharehol<strong>der</strong>s<br />

Sharehol<strong>der</strong>s<br />

(ma<strong>in</strong>ly)<br />

Sharehol<strong>der</strong>s<br />

Detailed criteria<br />

Internal risk model (VaR type),<br />

Solvency requirements,<br />

Rat<strong>in</strong>g agencies' requirements<br />

Economic earn<strong>in</strong>gs of 0 or less tolerated<br />

every ten years<br />

Concentration limits, maximum per-risk<br />

retention, etc.<br />

VaR limits for market and credit risk<br />

Supplementary criteria enhance robustness of SRMF<br />

29


Strategic Risk Management Framework<br />

Gesamtportfolio / Vermeidung von F<strong>in</strong>ancial Distress<br />

Insolvenz (Toleranz<br />

d. Versicherungsnehmer)<br />

F<strong>in</strong>ancial Distress<br />

(Toleranz d. Aktionärs)<br />

Höhe des Verlustes<br />

Risikotoleranz ausgedrückt als zulässige Wahrsche<strong>in</strong>lichkeit, dass e<strong>in</strong> gesetztes Limit<br />

überschritten wird. Für Vermeidung von F<strong>in</strong>ancial Distress e<strong>in</strong>e deutlich höhere<br />

Wahrsche<strong>in</strong>lichkeit als das Kriterium F<strong>in</strong>anzstärke, z.B. 1-<strong>in</strong>-5 to 1-<strong>in</strong>-25.<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

30


Die Subprime-Krise –<br />

Hat das <strong>Risikomanagement</strong> versagt?<br />

31


Strukturierte Produkte<br />

Was heißt das eigentlich? -<br />

Die Hauptbestandteile und Varianten von Asset-Backed Securities<br />

Source: Prof. L. Overbeck „Risikoadäquates Rat<strong>in</strong>g von Verbriefungstransaktionen“,<br />

Schmalenbach-Gesellschaft, 26.03.2004<br />

Elemente <strong>der</strong> Struktur Mögliches Un<strong>der</strong>ly<strong>in</strong>g<br />

R. Sachs – <strong>Risikomanagement</strong><br />

CLO Collateralised Loan Obligation<br />

CBO Collateralised Bond<br />

Obligation<br />

CSO Collateralised Credit Default<br />

Swap Obligation<br />

RMBS Residential Mortgage Backed<br />

Securities<br />

CMBS Commercial Mortgage<br />

Backed Securities<br />

CCMT Credit Card Master Trusts<br />

CL Consumer Loan ABS<br />

…<br />

27. August 2008<br />

32


Strukturierte Produkte<br />

Es gibt wenig Möglichkeiten, die zugrunde liegenden<br />

Risiken zu durchschauen<br />

Funded (cash)<br />

or unfunded<br />

Un<strong>der</strong>ly<strong>in</strong>g Risk<br />

(synthetic)<br />

transfer<br />

Transparenz<br />

CDO CDO²<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Komplexität<br />

Funded (cash)<br />

or unfunded<br />

(synthetic)<br />

Investment<br />

Investor<br />

27. August 2008<br />

33


Strukturierte Produkte<br />

Korrelation <strong>in</strong> den Kapitalmärkten<br />

How it REALLY works… … un<strong>der</strong> stress<br />

Source: “The Economist” 1997, IMF Global F<strong>in</strong>ancial Stability Report, April 2008<br />

Note: ABCP measures short-term fund<strong>in</strong>g (liquidity), CDS measures solvency<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

34


Strukturierte Produkte<br />

“E<strong>in</strong>e Investition <strong>in</strong> Strukturierte Produkte ist im<br />

wesentlichen e<strong>in</strong>e Wette auf die Korrelationsannahme!”<br />

Diversification?<br />

� Securitisation suppresses<br />

idiosyncratic risk<br />

� Systematic risk is enhanced <strong>in</strong><br />

every step of securitisation<br />

� CDO², CDO³, … have the<br />

highest level of systematic risk<br />

� Systematic risk is not<br />

diversifiable<br />

Correlation Drives the Loss Profile<br />

R. Sachs – <strong>Risikomanagement</strong><br />

Source: Reserve Bank of Australia, Bullet<strong>in</strong> November 2007<br />

27. August 2008<br />

35


Strukturierte Produkte<br />

E<strong>in</strong>ige Reaktionen des Managements waren den<br />

verän<strong>der</strong>ten Marktbed<strong>in</strong>gungen nicht angemessen…<br />

� Focus on growth, lack of clear strategy<br />

� Early warn<strong>in</strong>g signs, general<br />

uneas<strong>in</strong>ess <strong>in</strong> September 2006, yet no<br />

reaction by senior management<br />

� Resistance to change fund<strong>in</strong>g<br />

framework<br />

� Resistance to implement hard limits<br />

(proposal by treasury perceived as<br />

limitation of growth and rejected by<br />

CEOs)<br />

Management Action Possible Causes?<br />

� structural <strong>in</strong>centives: alpha creation<br />

based on low fund<strong>in</strong>g cost<br />

� Asymmetric risk/reward compensation:<br />

no adjustment for riskier positions, e.g.<br />

partial hedge preferred over full hedge<br />

� Insufficient <strong>in</strong>centives to protect<br />

reputation long-term: cash bonuses for<br />

short term performance of tra<strong>der</strong>s<br />

� Behavioural science: stick to prior<br />

beliefs, ignore contradict<strong>in</strong>g signs and<br />

experiences<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

36


Strukturierte Produkte<br />

… komb<strong>in</strong>iert mit unwirksamer <strong>Risikomanagement</strong><br />

Infrastruktur<br />

� Valuation: mark-to-market –<br />

which market?<br />

� No <strong>in</strong>ternal pric<strong>in</strong>g/valuation model<br />

� strong rat<strong>in</strong>g dependence<br />

� limited look-through & fundamental<br />

analysis<br />

Measurement & Control<br />

� exposure distortion by hedges<br />

� Reliance on statistical risk measures<br />

and lack of risk-factor limits<br />

� Many formal reports existed, but no<br />

comprehensive view, also due to<br />

<strong>in</strong>complete data<br />

� "Hedged" positions netted <strong>in</strong> reports<br />

� Individual limits, yet no comprehensive<br />

coverage<br />

Report<strong>in</strong>g<br />

� No “reliances and limitations” section<br />

Real risks not captured by the applied tools → Model Risk!<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

37


Quo vadis, <strong>Risikomanagement</strong>?<br />

38


Die Zukunft des Risiko Managements<br />

Imag<strong>in</strong>e Analyse Act<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

39


Was wir daraus lernen<br />

Imag<strong>in</strong>e<br />

“Wenn wir so denken, wie wir schon immer gedacht haben,<br />

bekommen wir das, was wir schon immer bekommen haben!”<br />

� New bus<strong>in</strong>ess <strong>in</strong>itiatives with clear strategy and consi<strong>der</strong>ation of impact on support<strong>in</strong>g units<br />

� Bus<strong>in</strong>ess case and plan based on realistic assumptions and with regular challenge<br />

� Silo mentality vs. cross-discipl<strong>in</strong>ary communication and discussion → ERM Family!<br />

� Scenario plann<strong>in</strong>g and analysis as fundamental risk management tool:<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

40


Was wir daraus lernen<br />

Analyse<br />

Erkennen und überwachen <strong>der</strong> relevanten<br />

Risiken<br />

Highly sophisticated models <strong>in</strong> place “All models are wrong! But some are useful.”<br />

� Reliances and Limitations openly addressed<br />

and clearly communicated<br />

� Fundamental analysis of un<strong>der</strong>ly<strong>in</strong>g risks<br />

� In-house valuation <strong>in</strong>stead of heavy<br />

(exclusive?) reliance on external parties, e.g.<br />

agency rat<strong>in</strong>gs<br />

� Comprehensive limit system: we surely have<br />

enough limits, but do we have the right ones?<br />

� Have measures <strong>in</strong> place to deal with model risk,<br />

e.g. nom<strong>in</strong>al budgets, stress tests<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

41


Was wir daraus lernen<br />

Act<br />

Why?<br />

M<strong>in</strong>imum<br />

Action<br />

Requirements<br />

Beachten von Frühwarnzeichen –<br />

Handeln bevor es zu spät ist!<br />

� Alignment of risk management functions with <strong>in</strong>centives (compensation)<br />

� Risk management functions need sufficient authority, not only <strong>in</strong>dependence<br />

� Risk management is beyond a remote pr<strong>in</strong>ciple & policy unit<br />

R. Sachs – <strong>Risikomanagement</strong><br />

27. August 2008<br />

42


Was wir daraus lernen<br />

E<strong>in</strong> Modell ist e<strong>in</strong> Modell ist e<strong>in</strong> Modell…<br />

≠<br />

E<strong>in</strong> Modell kann ke<strong>in</strong>e Entscheidung treffen –<br />

aber für die Entscheidungsf<strong>in</strong>dung sehr wertvoll se<strong>in</strong><br />

R. Sachs – <strong>Risikomanagement</strong> 27. August 2008<br />

43


Vielen Dank!<br />

Dr. Ra<strong>in</strong>er Sachs

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!